26 companies

hVIVO

hVIVO is a science-led early-phase drug development partner offering human challenge studies, clinical trial delivery, CL3 laboratories, regulatory consultancy, recruitment and cryostorage from sites in the UK and Germany.

BioNTech

BioNTech is a global biotechnology company, founded in 2008, developing mRNA and other immunotherapies for cancer and serious diseases, including the first approved COVID-19 mRNA vaccine with Pfizer.

Bicycle Therapeutics

Clinical-stage biopharmaceutical company founded in 2009 developing bicyclic peptide medicines for cancer and other diseases, headquartered in Cambridge, UK with operations in Lexington, Massachusetts.

Genmab

Genmab is an international biotechnology company developing antibody therapeutics for cancer and other serious diseases, with approved products and a clinical pipeline across five countries.

Abivax

Abivax is a clinical-stage biotechnology company founded in 2013 in Paris, developing oral microRNA-based therapeutics for chronic inflammatory diseases, led by obefazimod in ulcerative colitis.

Swedish Orphan Biovitrum

Sobi is a global biopharmaceutical company developing medicines for rare diseases, with expertise in haematology, immunology and specialty care, present in 30 countries.

bioMérieux

French multinational biotechnology company, founded 1963, developing in vitro diagnostics, reagents and software for healthcare, food safety and pharmaceutical quality control.

Oxford Biomedica

OXB is a cell and gene therapy CDMO developing and manufacturing viral vectors, with process development, GMP manufacturing, analytics, quality and regulatory services across five facilities in the UK, France and the US.

Genus

Genus is an animal genetics company using genomics, gene editing and reproductive technologies to breed healthier, more efficient livestock, with operations in over 70 countries.

Novonesis

Novonesis develops biology-based solutions - enzymes, functional proteins and microorganisms - for more than 30 industries, with over 10,000 employees.

Sartorius

Sartorius, founded in 1870, supplies bioprocess solutions, laboratory equipment and consumables to life sciences research and biopharmaceutical manufacturing, with over 13,500 employees across three regions.

GSK

GSK is a global biopharma company that discovers, develops and delivers medicines and vaccines across specialty medicines, vaccines and general medicines, including immunology, oncology, HIV and infectious diseases.

QIAGEN

QIAGEN, founded in 1984, develops Sample to Insight solutions - kits, instruments, assays and bioinformatics - that extract and interpret information from biological samples for diagnostics and research.

Autolus Therapeutics

Autolus Therapeutics is a London-based biopharmaceutical company developing programmed T cell therapies for cancer and autoimmune diseases; its AUCATZYL CAR T therapy received FDA approval in November 2024.

ALK-Abelló

ALK-Abelló is a Danish specialty pharmaceutical company researching and manufacturing allergy immunotherapy and related products, with production in four countries and offices in more than 20.

Jazz Pharmaceuticals

Dublin-headquartered biopharmaceutical company, founded in 2003, developing and commercializing medicines for rare diseases, epilepsy, oncology and sleep disorders.

UCB

UCB is a global biopharmaceutical company, founded in 1928 and headquartered in Brussels, that develops medicines and patient solutions for severe neurological and autoimmune diseases across nearly 40 countries.

argenx

argenx is a global immunology company engineering antibody-based treatments for severe autoimmune diseases, including VYVGART, approved for generalized myasthenia gravis.

Roivant Sciences

Roivant Sciences, founded in 2014, is a healthcare company that builds and operates focused subsidiaries to develop, seek approval for and commercialize medicines and technologies.

ICON plc

ICON plc is a global clinical research organisation providing outsourced development and commercialisation services to pharmaceutical, biotechnology, medical device and government clients.

COMPASS Pathways

A London-based biotechnology company developing COMP360, an investigational synthetic psilocybin treatment, through a global phase 3 programme in treatment-resistant depression.

AstraZeneca

AstraZeneca is a global, science-led biopharmaceutical company formed in 1999 that discovers, develops and commercialises prescription medicines used by millions of patients worldwide.

Virax Biolabs

Alkermes

Alkermes develops and commercializes medicines for psychiatric and neurological disorders, including addiction, serious mental illness and sleep disorders.